AKBA SG&A Expenses

Akebia Therapeutics Inc · SG&A Expenses

AKBA logo

AKBA SG&A Expenses

Latest reported$114.69M
AKBA SG&A Expenses ($2.89M → $114.69M)
High-resolution chart · PNG

AKBA sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Akebia Therapeutics Inc SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
107,480,000
106,545,000
100,233,000
138,601,000
174,140,000
154,099,000
149,455,000
87,061,000
27,008,000
22,210,000
18,497,000
12,542,000
5,151,621
2,891,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.